ArticleCancer science2018

Senescent cells re-engineered to express soluble programmed death receptor-1 for inhibiting programmed death receptor-1/programmed death ligand-1 as a vaccination approach against breast cancer.

Zehong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.